Anand Bhaskar
- SEC CIK
- 0001890784
No open-market purchases or sales filed in the past year.
Current role at each company
- SMMT Summit Therapeutics Inc.Chief Accounting Officeras of Jan 12, 2026
- RETA Reata Pharmaceuticals IncSVP, Chief Accounting Officeras of Sep 26, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Anand Bhaskar as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RETA Reata Pharmaceuticals Inc
SVP, Chief Accounting Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2023 (view filing) | Sep 5 | 2 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −406 | $169.20 | −$68.7K | −1.7%24.1K after | |
| Aug 17, 2023 (view filing) | Aug 15-16 | 2 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −403 | $168.73 | −$68.0K | −1.6%24.5K after | 2 lots |
| Jun 16, 2023 (view filing) | Jun 14 | 2 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −2.34K | $102.11 | −$239.2K | −8.6%24.9K after | |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −1.09K | $85.37 | −$92.7K | −4.1%25.7K after | 2 lots |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −165 | $84.58 | −$14.0K | −0.6%26.8K after | |
| Mar 6, 2023 (view filing) | Mar 3 | 3 days | Anand BhaskarSVP, Chief Accounting Officer | SSaleClass A common stock | −820 | $87.47 | −$71.7K | −3.0%26.9K after |